Bladder Outlet Obstruction Clinical Trial
Official title:
Bladder Outlet Obstruction Observation Using Dynamic Urine Vibration "Holter" With Correlation to Pressure Flow Study and Uroflowmetry.
Verified date | October 2014 |
Source | P. Square Medical Ltd |
Contact | n/a |
Is FDA regulated | No |
Health authority | Israel: Ethics Commission |
Study type | Interventional |
Current gold standard of bladder outlet diagnosis is pressure flow study. This study is invasive time consuming and requires expensive and complex set-up. In this study the investigators plan to evaluate an alternative technology that presumably is able to diagnose bladder outlet obstruction using a Dynamic Urine Vibration "Holter" based on a Urine Flow Vibration Analysis technology. The acoustic vibration sensor is a small device that records the vibration due to urine flow. The patient attaches the sensor to the penis using a disposable sensor patch for the duration of approximately one minute during one urination. The analysis is performed off-line and the results are compared to the results of a standard pressure flow study and to the standard free flowmetry test. The innovative technology for the diagnosis of bladder outlet obstruction is noninvasive, rapid and does not involve complex setup.
Status | Suspended |
Enrollment | 45 |
Est. completion date | June 2015 |
Est. primary completion date | June 2015 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - clinical diagnosis of benign prostatic hyperplasia (BPH) - has indication for urodynamic evaluation - Males 18 years and older - Capability of understanding and having signed the informed consent form after full discussion of the research, nature of the treatment, and its risks and benefits. Exclusion Criteria: Any condition which, in the investigator opinion, makes the patient unsuitable |
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Country | Name | City | State |
---|---|---|---|
Israel | Hadassah Medical Center | Jerusalem | |
Israel | Tel Aviv Sourasky Medical Center | Tel Aviv |
Lead Sponsor | Collaborator |
---|---|
P. Square Medical Ltd |
Israel,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Efficacy of Holter to confirm or exclude of bladder outlet obstruction | One recording at the time of urodynamic testing. (approximatly one minute) | No | |
Secondary | Efficacy of Holter to supply the free flowmetry test curve & values. | One recording at the time of urodynamic testing. (approximatly one minute) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03457805 -
Prostatic Artery Embolization in Advanced Prostate Cancer
|
N/A | |
Completed |
NCT00507455 -
Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction
|
Phase 2 | |
Recruiting |
NCT04626167 -
Concomitant Renal and Urinary Bladder Allograft Transplantation
|
Early Phase 1 | |
Not yet recruiting |
NCT06422312 -
A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients.
|
N/A | |
Not yet recruiting |
NCT01388348 -
Diagnosis of Bladder Outlet Obstruction Using Dynamic Urine Vibration "Holter" in Comparison to Pressure Flow Study
|
N/A | |
Completed |
NCT00710749 -
The Value of Multiple Urine Flow Rate Measurements in Male Benign Prostatic Hyperplasia (BPH) Subjects
|
N/A | |
Recruiting |
NCT03486639 -
Urodynamics and Clinical Factors That Are Associated With Bladder Over-sensitivity
|
||
Enrolling by invitation |
NCT02869061 -
Effectiveness and Safety of Adipose-derived Regenerative Cells for Reduction of Risk of Bladder Neck Contracture
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT05631080 -
Transurethral Prostate Enucleation in Surveillance Protocol for Low Risk Prostate Cancer
|
Phase 4 | |
Completed |
NCT02031653 -
Comparison Between Invasive Pressure Flow Study and Non-invasive Penile Cuff Test
|
||
Completed |
NCT00605319 -
An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic Hyperplasia
|
Phase 4 | |
Recruiting |
NCT03503721 -
Bipolar Transurethral Enucleation (BipolEP) vs Bipolar Transurethral Resection of the Prostate
|
N/A | |
Not yet recruiting |
NCT05910983 -
Prostate Enucleation With Intravesical Botox Injections in Treating BPH and Bladder Overactivity
|
N/A | |
Recruiting |
NCT03281798 -
Fetal Cystoscopy for Severe Lower Urinary Tract Obstruction
|
N/A | |
Completed |
NCT05470751 -
GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology
|
||
Completed |
NCT04981080 -
DU and BOO in Women With and Without Symptoms of VD
|
||
Completed |
NCT00410514 -
A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)
|
Phase 2 | |
Recruiting |
NCT06152666 -
Day-case Endourology; Enablers, Barriers, Unexpected Outcomes
|
||
Not yet recruiting |
NCT04514718 -
Low Energy HoLEP on IPSS
|
N/A | |
Completed |
NCT01661621 -
Antimuscarinics as the First-line Treatment for Male With IPSS-V/S≤1
|
Phase 4 |